Research Paper Volume 16, Issue 12 pp 10489—10511
Identification of a signature of histone modifiers in kidney renal clear cell carcinoma
Figure 9. Correlation between HMs-based signature and clinical characteristics and prognosis. (A) Analysis of differences in clinical characteristics (age, gender, grade and stage) of KIRC samples between high- and low-risk groups. (B) Analysis of survival differences between high- and low-risk KIRC samples from subgroup stratified by age (≤60 years and >60 years). (C) Analysis of survival differences between high- and low-risk KIRC samples from subgroup stratified by gender (FEMALE and MALE). (D) Analysis of survival differences between high- and low-risk KIRC samples from subgroup stratified by grade (G1-2 and G3-4). (E) Analysis of survival differences between high- and low-risk KIRC samples from subgroup stratified by stage (Stage I−II and Stage III−IV).